Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bataille

Showing results (211-220 of 322) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|April 15, 1989
Limiting dilution cloning of B cells from patients with multiple myeloma: emergence of non-malignant B-cell linesG Clofent, B Klein, T Commes, et al.
British Journal of Haematology|December 24, 1997
Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemiaM Paszek-Vigier, P Talmant, F Méchinaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Bone Marrow Transplantation|June 18, 1999
Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myelomaP Moreau, N Milpied, B Mahé, et al.
Cancer Research|August 15, 1995
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalizationC Pellat-Deceunynck, S Barillé, D Puthier, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 18, 1978
[Association of papular mucinosis and IgG lambda multiple myeloma]R Bataille, F Rosenberg, J Sany, et al.
British Journal of Haematology|December 1, 1990
Osteoblast stimulation in multiple myeloma lacking lytic bone lesionsR Bataille, D Chappard, C Marcelli, et al.
European Journal of Pharmacology|August 5, 2023
Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84Vincent B Luscombe, Luis Alberto Baena-López, Carole J R Bataille, et al.
British Journal of Cancer|June 11, 2009
Validation of UBE2C protein as a prognostic marker in node-positive breast cancerD Loussouarn, L Campion, F Leclair, et al.
British Journal of Haematology|November 1, 1995
High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cellsN Juge-Morineau, M P Mellerin, S Francois, et al.
Pageof 33

Showing results (211-220 of 322) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|April 15, 1989
Limiting dilution cloning of B cells from patients with multiple myeloma: emergence of non-malignant B-cell linesG Clofent, B Klein, T Commes, et al.
British Journal of Haematology|December 24, 1997
Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemiaM Paszek-Vigier, P Talmant, F Méchinaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Bone Marrow Transplantation|June 18, 1999
Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myelomaP Moreau, N Milpied, B Mahé, et al.
Cancer Research|August 15, 1995
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalizationC Pellat-Deceunynck, S Barillé, D Puthier, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 18, 1978
[Association of papular mucinosis and IgG lambda multiple myeloma]R Bataille, F Rosenberg, J Sany, et al.
British Journal of Haematology|December 1, 1990
Osteoblast stimulation in multiple myeloma lacking lytic bone lesionsR Bataille, D Chappard, C Marcelli, et al.
European Journal of Pharmacology|August 5, 2023
Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84Vincent B Luscombe, Luis Alberto Baena-López, Carole J R Bataille, et al.
British Journal of Cancer|June 11, 2009
Validation of UBE2C protein as a prognostic marker in node-positive breast cancerD Loussouarn, L Campion, F Leclair, et al.
British Journal of Haematology|November 1, 1995
High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cellsN Juge-Morineau, M P Mellerin, S Francois, et al.
Pageof 33